Renumbering of Courses for Harrison School of Pharmacy

Transcription

1 OFFICE OF ADADEMIC AND STUDENT AFFAIRS AUBURN UNIVERSITY HARRISON SCHOOL OF PHARMACY July 24, 2013 Memo To: Constance Relihan, Ph.D. Associate Provost for Undergraduate Education George Flowers, Ph.D. Dean, Graduate School From: Subject: Paul W. Jungnickel, Ph.D. Associate Dean for Academic and Student Affairs Renumbering of Courses for Harrison School of Pharmacy Due to the administrative authority for the Harrison School of Pharmacy (HSOP) being transferred to the Graduate School, I am submitting a request for renumbering of courses in the Doctor of Pharmacy program to the 9000 level. Please note the following materials that accompany this request. List of Courses to be Renumbered: The appended list contains all courses that will need to be renumbered. Please note that in the renumbering scheme, designations from the HSOP s three departments will be eliminated and all courses will carry the PYDI (Pharmacy Interdepartmental) designation. Please also note that many courses have been given two numbers, one ending in 0 and another ending in 6. Given the extensive use of videoconferencing in our program, we have been asked to do this by the Office of Institutional Research and Assessment in order to meet SACS accreditation standards. According to Dr. Drew Clark, all courses in which the instructor is not physically present in the classroom for at least 50 percent of the time are to be considered distance education courses and are to be given course numbers ending in 6. Thus the courses ending in 6 will primarily be used in two situations: 1. Courses which are primarily taught by Auburn Campus faculty members and are videoconferenced to the Mobile Campus: In these cases the Auburn Campus Students would be enrolled in a section with the course number ending in 0 and the Mobile Campus students would be enrolled in a section with the course number ending in Courses which are primarily taught by faculty members who are located at sites other than on the Auburn and Mobile Campuses: An example of this would be a course taught by a faculty member located at our Huntsville Clinical Education Center which is videoconferenced to both the Auburn and Mobile Campuses. In this case students 2316 Walker Building, Auburn, AL ; Telephone: ; Fax: w w w. a u b u r n. e d u

2 enrolled on both campuses would be placed in a course section with the course number ending in 6. List of Courses to be Deleted: These courses are no longer taught and need to be deleted from the Harrison School of Pharmacy s course inventory. The main reasons for deletion of these courses are the 2005 curricular revision of the Doctor of Pharmacy program which eliminated courses that were not removed from the inventory at that time and the closing of the Non- Traditional Doctor of Pharmacy degree program in List of Piggyback Courses: Seven courses are listed that are the 5000-level versions of piggyback courses offered by the Department of Pharmacal Sciences. The HSOP has no intention of continuing to offer these courses to Doctor of Pharmacy students. Since 6000-level courses cannot stand alone without a 5000-level version, the Department of Pharmacal Sciences will review the need for these courses. If the Department determines that these courses need to be offered to MS and PhD students, then it will submit for approval the required curricular requests. Revised Bulletin Descriptions for all Courses that are Renumbered at the 9000-level Please let me know if there is additional information I can provide or if you have questions. C: Dr. R. Lee Evans, Dean Dr. David Riese, Associate Dean for Research and Graduate Education Dr. George Crandell, Associate Dean, Graduate School

3 Changes in Course Numbers Harrison School of Pharmacy Doctor of Pharmacy Program Old Course Numbers New Course Numbers PYDI 5000 DRUGS AND DISEASES I (5) PYDI 9000/9006 DRUGS AND DISEASES I (5) PYPC 5010 PATIENT CENTERED SKILLS (3) PYDI 9010/9016 PATIENT CENTERED SKILLS (3) PYDI 5020 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE I (2) PYDI 9020 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE I (2) PYDI 5080 FOUNDATIONS OF PHARMACY (1) PYDI 9080 FOUNDATIONS OF PHARMACY (1) PYDI 5090 PHARMACY PRACTICE EXPERIENCE I (2) PYDI 9090 PHARMACY PRACTICE EXPERIENCE I (2) PYDI 5100 DRUGS AND DISEASES II (5) PYDI 9100/9106 DRUGS AND DISEASES II (5) PYPC 5110 PHARMACY LAW AND ETHICS (2) PYDI 9110/9116 PHARMACY LAW AND ETHICS (2) PYDI 5120 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE II (2) PYDI 9120 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE II (2) PYDI 5130 DRUG LITERATURE EVALUATION (2) PYDI 9130/9136 DRUG LITERATURE EVALUATION (2) PYDI 5140 PRINCIPLES OF PHARMACOKINETICS (3) PYDI 9140/9146 PRINCIPLES OF PHARMACOKINETICS (3) PYDI 5190 PHARMACY PRACTICE EXPERIENCE II (2) PYDI 9190 PHARMACY PRACTICE EXPERIENCE II (2) PYDI 5200 DRUGS AND DISEASES III (8) PYDI 9200/9206 DRUGS AND DISEASES III (8) PYPC 5210 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUTION I (3) PYDI 9210/9216 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUATION I (3) PYDI 5220 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE III (2) PYDI 9220 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE III (2) PYPS 5230 DRUG PRODUCTS I (3) PYDI 9230/9236 DRUG PRODUCTS I (3) PYDI 5290 PHARMACY PRACTICE EXPERIENCE III (2) PYDI 9290 PHARMACY PRACTICE EXPERIENCE III (2) PYDI 5300 DRUGS AND DISEASES IV (8) PYDI 9300/9306 DRUGS AND DISEASES IV (8) PYPC 5310 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUATION II (3) PYDI 9310/9316 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUATION II (3) PYDI 5320 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE IV (2) PYDI 9320 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE IV (2) PYPS 5330 DRUG PRODUCTS II (3) PYDI 9330/9336 DRUG PRODUCTS II (3) PYDI 5390 PHARMACY PRACTICE EXPERIENCE IV (2) PYDI 9390 PHARMACY PRACTICE EXPERIENCE IV (2) PYDI 5420 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE V (2) PYDI 9420 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE V (2) PYDI 5470 INTEGRATED PHARMACOTHERAPY I (6) PYDI 9470 INTEGRATED PHARMACOTHERAPY I (6) PYDI 5480 INTEGRATED PHARMACOTHERAPY II (6) PYDI 9480 INTEGRATED PHARMACOTHERAPY II (6) PYDI 5490 PHARMACY PRACTICE EXPERIENCE V (2) PYDI 9490 PHARMACY PRACTICE EXPERIENCE V (2) PYDI 5520 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE VI (2) PYDI 9520 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE VI (2) PYDI 5570 INTEGRATED PHARMACOTHERAPY III (6) PYDI 9570 INTEGRATED PHARMACOTHERAPY III (6)

4 PYDI 5580 INTEGRATED PHARMACOTHERAPY IV (6) PYDI 9580 INTEGRATED PHARMACOTHERAPY IV (6) PYDI 5590 PHARMACY PRACTICE EXPERIENCE VI (2) PYDI 9590 PHARMACY PRACTICE EXPERIENCE VI (2) PYPP 5600 DRUG INFORMATION SELECTIVE (5) PYDI 9600 DRUG INFORMATION SELECTIVE (5) PYPP 5610 COMMUNITY PHARMACEUTICAL CARE (5) PYDI 9610 COMMUNITY PHARMACEUTICAL CARE (5) PYPP 5620 MEDICINE I (5) PYDI 9620 MEDICINE I (5) PYPP 5630 MEDICINE II SELECTIVE (5) PYDI 9630 MEDICINE II SELECTIVE (5) PYPP 5640 PRIMARY/AMBULATORY CARE I (5) PYDI 9640 PRIMARY/AMBULATORY CARE I (5) PYPP 5650 PRIMARY/AMBULATORY CARE II (5) PYDI 9650 PRIMARY/AMBULATORY CARE II (5) PYPP 5660 HEALTH SYSTEM PRACTICE (5) PYDI 9660 HEALTH SYSTEM PRACTICE (5) PYPP 5670 PRACTICE ELECTIVE I (5) PYDI 9670 PRACTICE ELECTIVE I (5) PYPP 5680 PRACTICE ELECTIVE II (5) PYDI 9680 PRACTICE ELECTIVE II (5) PYPP 5690 PROFESSIONAL SEMINAR (1) PYDI 9690 PROFESSIONAL SEMINAR (1) PYPP 5700 ADVANCED PRACTICE EXPERIENCE PROFESSIONAL COMMUNICATION (0) PYDI 9700 ADVANCED PRACTICE EXPERIENCE PROFESSIONAL COMMUNICATION (0) PYPP 5710 METABOLIC SYNDROME (2) PYDI 9710/9716 METABOLIC SYNDROME (2) PYPC 5720 MOTIVATIONAL INTERVIEWING (2) PYDI 9720/9726 MOTIVATIONAL INTERVIEWING (2) PYPP 5730 DRUGS IN PREGNANCY (2) PYDI 9730/9736 DRUGS IN PREGNANCY (2) PYPP 5740 PEDIATRIC PHARMACOTHERAPY (2) PYDI 9740/9746 PEDIATRIC PHARMACOTHERAPY (2) PYPP 5750 ANTITHROMBOTIC/THROMBOLYTIC THERAPY (2) PYDI 9750/9756 ANTITHROMBOTIC/THROMBOLYTIC THERAPY (2) PYPP 5770 WOMEN S HEALTH ISSUES (2) PYDI 9770/9776 WOMEN S HEALTH ISSUES (2) PYPP 5780 ACUTE CARE PHARMACOTHERAPY (2) PYDI 9780/9786 ACUTE CARE PHARMACOTHERAPY (2) PYPP 5790 PSYCHIATRIC PHARMACOTHERAPY (2) PYDI 9790/9796 PSYCHIATRIC PHARMACOTHERAPY (2) PYPP 5810 EVIDENCE-BASED PHARMACOTHERAPY (2) PYDI 9810/9816 EVIDENCE-BASED PHARMACOTHERAPY (2) PYPP 5970 SPECIAL TOPICS IN PHARMACY PRACTICE (2) PYDI 9970/9976 SPECIAL TOPICS IN PHARMACY (2) PYPS 5900 SPECIAL PROBLEMS IN PHARMACAL SCIENCES (1-3)* PYPP 5960 SPECIAL PROBLEMS IN PHARMACY PRACTICE (1-3)* PYDI 9960 SPECIAL PROBLEMS IN PHARMACY (1-3)*

5 Courses to be Deleted Harrison School of Pharmacy Doctor of Pharmacy Program Course Number/Title PYDI 5133 DRUG LITERATURE EVALUATION (2) PYDI 5360 PHARMACOTHERAPY 1 (3) PYDI 5363 PHARMACOTHERAPY 1 (3) PYDI 5370 PHARMACOTHERAPY 2 (3) PYDI 5373 PHARMACOTHERAPY 2 (3) PYDI 5400 PHARMACOTHERAPY 3 (3) PYDI 5403 PHARMACOTEHRAPY 3 (3) PYDI 5410 PHARMACOTHERAPY 4 (3) PYDI 5413 PHARMACOTEHRAPY 4 (3) PYDI 5423 PHARMACOTHERAPY 5 (3) PYDI 5430 PHARMACOTHERAPY 6 (3) PYDI 5433 PHARMACOTEHRAPY 6 (3) PYPP 5550 DRUG INDUCED DISEASE (2) PYPP 5553 DRUG INDUCED DISEASE (2) PYDI 5500 PHARMACOTHERAPY 7 (3) PYDI 5503 PHARMACOTHERAPY 7 (3) PYDI 5523 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE VI Reason for Deletion Course incorrectly included in course listings at the time of a previous curricular revision, and is not being

6 PYDI 5510 PHARMACOTHERAPY 8 (3) PYDI 5513 PHARMACOTHERAPY 8 (3) PYDI 5523 PHARMACOTHERAPY 9 (3) PYDI 5530 PHARMACOTHERAPY 10 (3) PYDI 5533 PHARMACOTHERAPY 10 (3) PYPC 5710 INSTITUTIONAL PHARMACY 1 (3) PYPP 5760 SELF CARE AND NONPRESCRIPTION MEDICATION (2) PYPP 5963 SPECIAL PROBLEMS IN PHARMACY PRACTICE (1-3) Course has not been taught at least 8 years and there is no intention to resume teaching it. Course has not been taught at least 3 years and there is no intention to resume teaching it.

7 PIGGYBACK COURSES: The following courses are listed in the Auburn University Bulletin as piggyback courses. In the distant past these courses were offered as 5000 Level courses to Doctor of Pharmacy Students. The Harrison School of Pharmacy does not intend to offer these courses in the future to Doctor of Pharmacy Students and is requesting that they be deleted. If the Department of Pharmacal Sciences that these courses need to be offered to MS and PhD students, then the Department will submit the required curricular requests. PYPS 5310 PHARMACOLOGY 1 (3) PYPS 5320 PHARMACOLOGY 2 (3) PYPS 5350 TOXICOLOGY (3) PYPS 5360 CELLULAR PHARMACOLOGY (3) PYPS 5370 FUNDAMENTALS OF BIONUCLEONICS (3) PYPS 5390 NEUROPHARMACOLOGY OF DRUG ABUSE (3) PYPS 5500 PHARMACOGNOSY (3)

8 HARRISON SCHOOL OF PHARMACY: Catalog listings for Doctor of Pharmacy Program PYDI 9000/9006 DRUGS AND DISEASES I (5). LEC. 5. Integrated study of pathophysiology and chemical, pharmacological, biotechnology, and pharmacokinetic principles to explain the action of drugs. Fall. PYDI 9010/9016 PATIENT CENTERED SKILLS (2). LEC. 2. Development of methods for developing positive, therapeutic relationships with patients through the application of communications skills (empathy, assertiveness training, effective listening, etc.) and other behavioral interventions. Fall. PYDI 9020 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE I (2). LEC. 1, LAB. 2. This course integrates the skills necessary for the provision of pharmaceutical care. Source material introduces and integrates knowledge and skills focusing on patient assessment and communication. Fall. PYDI 9080 FOUNDATIONS OF PHARMACY (1). WSP. 1. One-week experience orienting first year PYDI students to the context, concepts, tools, and skills necessary for understanding of, and success in, pharmacy education. Fall. PYDI 9090 PHARMACY PRACTICE EXPERIENCE I (2). PRA. 2. SU. First of a six-course sequence of introductory practice experience in which the concept of pharmaceutical care is introduced by the provision of basic care to community based patients. Fall. PYDI 9100/9106 DRUGS AND DISEASES II (5). LEC. 5. Pr., PYDI 9000/9006 Presents, in an integrated manner, pathophysiology and chemical, pharmacological and biotechnology principles to explain the action of drugs; continuation of PYDI 9000/9006. Spring. PYDI 9110/9116 PHARMACY LAW AND ETHICS (2). LEC. 2. Basic legal and ethical principles of pharmaceutical care and their effect on the patiehnt drug use process. Spring. PYDI 9120 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE II (2). LEC. 1, LAB. 2. Pr., PYDI 9020 This course integrates pharmaceutical care skills. Source material introduces and integrates knowledge and skills focusing on pharmaceutical calculations, communication, physical assessment and use of clinical literature. Spring. PYDI 9130/9136 DRUG LITERATURE EVALUATION (2). LEC. 2. Development of the ability to effectively and efficiently retrieve drug information and critically evaluate and interpret studies published in the medical and pharmaceutical literature. Spring. PYDI 9140/9146 PRINCIPLES OF PHARMACOKINETICS (3). LEC. 3. Pr., PYDI 9000/9006 To prepare students to use pharmacokinetic information and measurements to evaluate drug therapy and recommend appropriate dosing strategies for drug administration and monitoring. Spring. PYDI 9190 PHARMACY PRACTICE EXPERIENCE II (2). PRA. 2. SU. Pr., PYDI 9090 Second of a six-course sequence of introductory practice experience in which the concept of pharmaceutical care is introduced by the provision of basic care to community-based based patients. Spring. PYDI 9200/9206 DRUGS AND DISEASES III (8). LEC. 8. Pr., PYDI 9100/9106 and PYDI 9140/9146 Presentation in an integrated manner of path physiology and chemical, pharmacological, biotechnology, and pharmacokinetic principles to explain the action of drugs. Continuation of PYDI 9100/9106. Fall. PYDI 9210/9216 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUATION I (3). LEC. 3. Overview of the development, management, and evaluation of systems that support the provision of pharmaceutical care for patients in multiple health systems. Fall. PYDI 9220 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE III (2). LEC. 1, LAB. 2. Pr., PYDI 9120 Integrates the provision of pharmaceutical care and pharmacy-specific skills related to drug-related problems. Supportive skills for the pharmaceutical sciences and other integrated skills are a major emphasis. Fall. PYDI 9230/9236 DRUG PRODUCTS I (3). LEC. 3. Pr., PYDI 9100/9106 and PYDI 9120 Physical-chemical and biopharmaceutical principles and technologies used in the preparation of pharmaceutical dosage forms and novel drug delivery systems. Fall. PYDI 9290 PHARMACY PRACTICE EXPERIENCE III (2). PRA. 2. SU. Pr., PYDI 5190 Third in six-course sequence of introductory practice experience in which pharmaceutical care is provided to moderately complex community based patients. Fall. PYDI 9300/9306 DRUGS AND DISEASES IV (8). LEC. 8. Pr., PYDI 9200/9206 Presentation, in an integrated manner, of pathophysiology and chemical, pharmacological, biotechnology, and pharmacokinetic principles to explain the action of drugs. Continuation of PYDI 9200/9206. Spring. PYDI 9310/9316 PHARMACY PRACTICE DEVELOPMENT, MANAGEMENT, AND EVALUATION II (3). LEC. 3. Pr., PYPC 9210/9216 An overview of the development, management, and evaluation of systems that support the provision of pharmaceutical care for patients in multiple health systems. Continuation of PYPC 9210/9216. Spring. PYDI 9320 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE IV (2). LEC. 1, LAB 2. Pr., PYDI 9220 Continuation of PYDI Spring. PYDI 9330/9336 DRUG PRODUCTS II (3). LEC. 3. Pr., PYDI 9230/9236 and PYDI 9200/9206 and PYDI 9220 Physical-chemical and biopharmaceutical principles and technologies used in the preparation of pharmaceutical dosage forms and novel drug delivery systems. Continuation of PYPS 9230/9236. Spring. PYDI 9390 PHARMACY PRACTICE EXPERIENCE IV (2). PRA. 2. SU. Pr., PYDI 9290 Fourth in a six-course sequence of introductory practice experience in which pharmaceutical care is provided to moderately complex community based patients. Spring. PYDI 9420 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE V (2). LEC. 1, LAB 2. Continuation of PYDI 9320 Fall. PYDI 9470 INTEGRATED PHARMACOTHERAPY I (6) RCT. 6. Application of the basic, clinical, and socio-behavioral sciences to identifying, preventing and solving health and drug related problems. Fall. PYDI 9480 INTEGRATED PHARMACOTHERAPY II (6) RCT. 6. Continuation of PYDI Fall. PYDI 9490 PHARMACY PRACTICE EXPERIENCE V (2). PRA. 2. SU. Fifth in a six-course sequence of introductory practice experiences in which pharmaceutical care is provided to increasingly complex community based patients along with patient care team management responsibilities. Fall. PYDI 9520 CONTEMPORARY ASPECTS OF PHARMACY PRACTICE VI (2). LEC. 1, LAB 2. Pr., PYDI 9420 Continuation of PYDI PYDI 9570 INTEGRATED PHARMACOTHERAPY III (6) RCT. 6. Pr., PYDI 9480 Continuation of PYDI Spring. PYDI 9580 INTEGRATED PHARMACOTHERAPY IV (6) RCT. 6. Continuation of PYDI Spring. PYDI 9590 PHARMACY PRACTICE EXPERIENCE VI (2). PRA. 2. SU. Pr., PYDI9490 Sixth in a six-course sequence of introductory practice experiences in which pharmaceutical care is provided to increasingly complex community based patients along with patient care team management responsibilities. Spring. PYDI 9600 DRUG INFORMATION-SELECTIVE (5). PRA. 5. Advanced practice experience in providing drug information services to health care providers. Fall, Spring, Summer

9 PYDI 9610 COMMUNITY PHARMACEUTICAL CARE (5). PRA. 5. Advanced Practice Experience in a community pharmacy practice setting that provides pharmaceutical care services such as disease management and other advanced patient care activities. Fall, Spring, Summer. PYDI 9620 MEDICINE I (5). PRA. 5. Advanced practice experience in providing Inpatient Pharmaceutical Care. Fall, Spring, Summer. PYDI 9630 MEDICINE II - SELECTIVE (5). PRA. 5. Advanced practice experience in providing Inpatient Pharmaceutical Care. Additional experience beyond PYDI Fall, Spring, Summer. PYDI 9640 PRIMARY/AMBULATORY CARE I (5). PRA. 5. Advanced practice experience in providing pharmaceutical care to patients as they initially access the health care system. Fall, Spring, Summer. PYDI 9650 PRIMARY/AMBULATORY CARE II (5). PRA. 5. Advanced practice experience in providing pharmaceutical care to patients as they initially access the health care system. Continuation of PYDI Fall, Spring, Summer. PYDI 9660 HEALTH SYSTEM PRACTICE (5). PRA. 5. Advanced practice experience in a health system setting that prepares the student to adapt and function within systems of integrated pharmaceutical care services. Fall, Spring, Summer. PYDI 9670 PRACTICE ELECTIVE I (5). PRA. 5. Elective experience in an advanced practice experience setting in which the student establishes personal learning goals and responsibilities. Fall, Spring, Summer. PYDI 9680 PRACTICE ELECTIVE II (5). PRA. 5. Elective experience in an advanced practice experience setting in which the student establishes personal learning goals and responsibilities. Fall, Spring, Summer. PYDI 9690 PROFESSIONAL SEMINAR (1). PRA. 1. SU. Student will demonstrate the ability to evaluate and synthesize pertinent literature, and effectively communicate pharmacotherapy-related material in one platform (seminar) presentation. Spring. PYDI 9700 ADVANCED PRACTICE EXPERIENCE PROFESSIONAL COMMUNICATION (0). PRA. SU. Students will synthesize pertinent literature, and communicate pharmacotherapy-related material in patient, journal club, in-service, and written presentations. Spring. PYDI 9710/9716 METABOLIC SYNDROME (2). LEC. 2. Advanced material on the assessment and treatment of disease states related to Metabolic Syndrome. Spring. PYDI 9720/9726 MOTIVATIONAL INTERVIEWING (2). LEC. 2. Pr., PYDI 9010/9016 Basic and advanced training and exploration of motivational interviewing. Fall PYDI 9730/9736 DRUGS IN PREGNANCY (2). LEC. 2. Medication issues related to pregnancy and lactation. Fall PYDI 9740/9746 PEDIATRIC PHARMACOTHERAPY (2). LEC. 2. Medication issues related to the pediatric population. Fall. PYDI 9750/9756 ANTITHROMBOTIC/THROMBOLYTIC THERAPY (2). LEC. 2. Provides the student with a working knowledge of both basic and advanced pharmacotherapeutics issues related to antithrombotic and thrombolytic therapy. Spring. PYDI 9770/9776 WOMEN S HEALTH ISSUES (2). LEC. 2. Understanding factors that affect women s premature morbidity and mortality. Fall. PYDI 9780/9786 ACUTE CARE PHARMACOTHERAPY (2). LEC. 2 This course is designed to orient the pharmacy student to the acute care environment and familiarize them with patient disease states and pharmacotherapy associated with the acutely ill patient. Spring. PYDI 9790/9796 PSYCHIATRIC PHARMACOTHERAPY (2). LEC. 2. To expose pharmacy students to psychiatry and to develop a working knowledge of both basic and advanced pharmacotherapeutic issues related to psychopharmacology. Spring. PYDI 9810/9816 EVIDENCE-BASED PHARMACOTHERAPY (2). LEC. 2. Student pharmacists will become more proficient at literature evaluation and application of evidence-based pharmacotherapy/medicine to patient care. Spring. PYDI 9960 SPECIAL PROBLEMS IN PHARMACY (1-3). IND. Independent study of problems related to pharmacy under the direction of a faculty member. Departmental approval. Course may be repeated for a maximum of 6 credit hours. Fall, Spring. PYDI 9970/9976 SPECIAL TOPICS IN PHARMACY (2). LEC. 2. Instruction and discussion in a selected current topic in Pharmacy. Course may be repeated for a maximum of 4 credit hours. Fall, Spring.

10 Pharmacal Sciences (PYPS) PYPS 5310 PHARMACOLOGY 1 (3). LEC. 3. Biochemical and physiological effects, action mechanism, absorption, distribution, biotransformation, excretion, therapeutic and other uses of drugs. PYPS 5320 PHARMACOLOGY 2 (3). LEC. 3. Biochemical and physiological effects, action mechanism, absorption, distribution, biotransformation, excretion and therapeutic and other uses of drugs. PYPS 5350 TOXICOLOGY (3). LEC. 3. The basic science of poisons including the acute and chronic toxicology of common environmental, agricultural, industrial, commercial, medicinal and naturally occurring substances. PYPS 5360 CELLUAR PHARMACOLOGY (3). LEC. 3. Cytological basis of pharmacodynamics including drug receptor interactions, drug metabolism, and characteristics of adverse drug reactions. PYPS 5370 FUNDAMENTALS OF BIONUCLEONICS (3). LEC. 3. Theoretical and practical applications of trace-level radioactivity for research application to pharmacy and allied sciences. PYPS 5390 NEUROPHARMACOLOGY OF DRUG ABUSE (2). LEC. 2. Pr., PYDI 5300 An in-depth study of drugs of abuse, including mechanisms of action. pharmacokinetics, addition, physical dependence and the effects of drug use during pregnancy. Substance abuse treatment strategies will also be discussed. Departmental approval. PYPS 5500 PHARMACOGNOSY (3). LEC. 3. Medicinal plants, folk medicines, herbal drugs and poisonous plants including constituents and uses. PYPS 5900 SPECIAL PROBLEMS IN PHARMACAL SCIENCES (1-3). LEC. Selected laboratory research topics in pharmacal sciences. Departmental approval. Course may be repeated for a maximum of 9 credit hours. PYPS 6310 PHARMACOLOGY 1 (3). LEC. 3. Biochemical and physiological effects, action mechanism, absorption, distribution, biotransformation, excretion, therapeutic and other uses of drugs. PYPS 6320 PHARMACOLOGY 2 (3). LEC. 3. Biochemical and physiological effects, action mechanism, absorption, distribution, biotransformation, excretion and therapeutic and other uses of drugs. PYPS 6330 PHARMACOLOGY 3 (3). LEC. 3. Biochemical and physiological effects, action mechanism, absorption, distribution, biotransformation, excretion and therapeutic and other uses of drugs. PYPS 6350 TOXICOLOGY (3). LEC. 3. The basic science of poisons including the acute and chronic toxicology of common environmental, agricultural, industrial, commercial, medicinal and naturally occurring substances. PYPS 6360 CELLUAR PHARMACOLOGY (3). LEC. 3. Cytological basis of pharmacodynamics including drug receptor interactions, drug metabolism, and characteristics of adverse drug reactions. PYPS 6370 FUNDAMENTALS OF BIONUCLEONICS (3). LEC. 3. Theoretical and practical applications of trace-level radioactivity for research application to pharmacy and allied sciences. PYPS 6390 NEUROPHARMACOLOGY OF DRUG ABUSE (2). LEC. 2. An in-depth study of drugs of abuse, including mechanisms of action, pharmacokinetics, addiction, physical dependence and the effects of drug use during pregnancy. Substance abuse treatment strategies will also be discussed. Departmental approval. PYPS 6500 PHARMACOGNOSY (3). LEC. 3. Medicinal plants, folk medicines, herbal drugs and poisonous plants including constituents and uses.